Diffuse large B-cell lymphoma arising from donor lymphoid cells after renal and pancreatic transplantation

Annals of Hematology

Volumn 82, Issue 2, 2003, Pages 131-135

  Cibeira, M T ^a   Lopez Guillermo, A ^a   Colomer, D ^a   Ricart, M J ^a   Alcaraz, A ^a   Martinez, A ^a   Campo, E ^a   Montserrat, E ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Chimerism analysis; Diffuse large B cell lymphoma; Ebstein Barr virus; Rituximab; Transplantation

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; GALLIUM 67; INSULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RITUXIMAB; VINCRISTINE;

ACUTE GRAFT REJECTION; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CASE REPORT; CHIMERA; DRUG DOSE REGIMEN; DRUG RESPONSE; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; KIDNEY TUMOR; LARGE CELL LYMPHOMA; LYMPHOID CELL; ORGAN DONOR; PANCREAS BIOPSY; PANCREAS TRANSPLANTATION; PANCREAS TUMOR; PRIORITY JOURNAL; SIDE EFFECT; SURGICAL TECHNIQUE; TUMOR LOCALIZATION; VIRUS INFECTION; ADULT; HISTOCOMPATIBILITY; LYMPHOCYTE; MALE; PATHOLOGY; VIROLOGY;

ADULT; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; LYMPHOCYTES; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; PANCREAS TRANSPLANTATION; PANCREATIC NEOPLASMS; TRANSPLANTATION CHIMERA;

EID: 0038690580     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0591-z     Document Type: Article

References (19)

1. Chadburn A, Suciu-Foca N, Cesarman E et al. (1995) Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin. Am J Pathol 147:1862-1870
2. Bustillo M, Perez Melon C, Otero Glz A et al. (2000). High grade lymphoma in a post-renal transplant patient. Description of a case and literature review (letter). Nephron 84:189-191
3. Swinnen LJ (2000) Diagnosis and treatment of transplant-related lymphoma. Ann Oncol 11 [Suppl 1]:45-48
4. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987-994
5. Ziegle JS, Su Y, Corcoran et al. (1992) Application of automated DNA sizing technology for genotyping microsatellite loci. Genomics 15:1026-1031
6. Pfeffer PF (1999) Cancer in organ transplanted patients. Tidsskr Nor Laegeforen 119:3792-3794
7. Penn I (2000) Cancers in renal transplant recipients. Adv Ren Replace Ther 7:147-156
8. Shapiro RS, McClain K, Frizzera G et al. (1988) Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:1234-1243
9. Zutter MM, Martin PJ, Sale GE et al. (1988) Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72:520-529
10. Swerdlow SH (1997) Classification of post-transplant lymphoproliferative disorders: from past to present. Semin Diagn Pathol 14 [Suppl 1]:2-7
11. Gaidano G, Dalla-Favera R (2000) Pathobiology of non-Hodgkin lymphomas. In: Hoffman R, Benz EJ Jr, Shattil SJ et al. (eds) Hematology: basic principles and practice, 3rd edn. Churchill Livingstone, Philadelphia, p 1224
12. Armitage JM, Kormos RL, Stuart RS et al. (1991) Posttransplant lymphoproliferative disease in thoracic organ transplant patients: 10 years of cyclosporine-based immunosuppression. J Heart Lung Transplant 10:877-886
13. Cesarman E, Chadburn A, Liu YF et al. (1998) BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome. Blood 92:2294-2302
14. Benkerrou M, Jais JP, Leblond V et al. (1998) Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome. Blood 92:3137-3147
15. Grillo-Lopez AJ, White CA, Varns C et al. (1999) Overview of the clinical development of rituximab: first monoclonal anti-body approved for the treatment of lymphoma. Semin Oncol 26 [Suppl 14]:66-73
16. Schilder R (1999) Rituximab immunotherapy. Cancer Biother Radiopharm 14 [Suppl 4]:237-240
17. White CA (1999) Rituximab immunotherapy for non Hodgkin's lymphoma. Cancer Biother Radiopharm 14 [Suppl 4]:241-250
18. Kosits C, Callaghan M (2000) Rituximab: a new monoclonal antibody therapy for non-Hodgkin's lymphoma. Oncol Nurs Form 27 [Suppl 1]:51-59
19. Milpied N, Vasseur B, Parquet N et al. (2000) Humanized anti-CD20 monoclonal antibody (Rituximab) in post-transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. Ann Oncol 11 [Suppl 1]:113-116